339 related articles for article (PubMed ID: 37304411)
1. circRNAs in drug resistance of breast cancer.
Misir S; Yaman SO; Petrović N; Sumer C; Hepokur C; Aliyazicioglu Y
Oncol Res; 2022; 30(4):157-172. PubMed ID: 37304411
[TBL] [Abstract][Full Text] [Related]
2. Circular RNAs: novel regulators of resistance to systemic treatments in breast cancer.
Guo XQ; Hua YM
Neoplasma; 2022 Sep; 69(5):1019-1028. PubMed ID: 35900318
[TBL] [Abstract][Full Text] [Related]
3. Cell density modulates chemoresistance in breast cancer cells through differential expression of ABC transporters.
Shivhare S; Das A
Mol Biol Rep; 2023 Jan; 50(1):215-225. PubMed ID: 36319789
[TBL] [Abstract][Full Text] [Related]
4. Circular RNAs in the chemoresistance of triple-negative breast cancer: A systematic review.
Wang H; Shan X; Peng Y; Zhou W
Drug Dev Res; 2023 Aug; 84(5):805-814. PubMed ID: 37114737
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA FAT atypical cadherin 1 (circFAT1)/microRNA-525-5p/spindle and kinetochore-associated complex subunit 1 (SKA1) axis regulates oxaliplatin resistance in breast cancer by activating the notch and Wnt signaling pathway.
Yao Y; Li X; Cheng L; Wu X; Wu B
Bioengineered; 2021 Dec; 12(1):4032-4043. PubMed ID: 34288822
[TBL] [Abstract][Full Text] [Related]
6. Deciphering the impact of circRNA-mediated autophagy on tumor therapeutic resistance: a novel perspective.
Wang T; He M; Zhang X; Guo Z; Wang P; Long F
Cell Mol Biol Lett; 2024 Apr; 29(1):60. PubMed ID: 38671354
[TBL] [Abstract][Full Text] [Related]
7. Autophagy-associated circRNA circCDYL augments autophagy and promotes breast cancer progression.
Liang G; Ling Y; Mehrpour M; Saw PE; Liu Z; Tan W; Tian Z; Zhong W; Lin W; Luo Q; Lin Q; Li Q; Zhou Y; Hamai A; Codogno P; Li J; Song E; Gong C
Mol Cancer; 2020 Mar; 19(1):65. PubMed ID: 32213200
[TBL] [Abstract][Full Text] [Related]
8. Hsa_circ_0097922 promotes tamoxifen resistance and cell malignant behaviour of breast cancer cells by regulating ACTN4 expression via miR-876-3p.
Liang X; Liu X; Song Z; Zhu J; Zhang J
Clin Exp Pharmacol Physiol; 2022 Dec; 49(12):1257-1269. PubMed ID: 35856314
[TBL] [Abstract][Full Text] [Related]
9. The biogenesis, function and clinical significance of circular RNAs in breast cancer.
Zeng Y; Zou Y; Gao G; Zheng S; Wu S; Xie X; Tang H
Cancer Biol Med; 2021 Jun; 19(1):14-29. PubMed ID: 34110722
[TBL] [Abstract][Full Text] [Related]
10. Functions and mechanisms of circular RNAs in cancer radiotherapy and chemotherapy resistance.
Cui C; Yang J; Li X; Liu D; Fu L; Wang X
Mol Cancer; 2020 Mar; 19(1):58. PubMed ID: 32171304
[TBL] [Abstract][Full Text] [Related]
11. The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer.
Wang Y; Wang Y; Qin Z; Cai S; Yu L; Hu H; Zeng S
Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):291-306. PubMed ID: 33544643
[TBL] [Abstract][Full Text] [Related]
12. Current research on circular RNAs and their potential clinical implications in breast cancer.
Liu D; Fang L
Cancer Biol Med; 2021 May; 18(3):635-48. PubMed ID: 34018386
[TBL] [Abstract][Full Text] [Related]
13. Circular RNAs: Their Role in the Pathogenesis and Orchestration of Breast Cancer.
He X; Xu T; Hu W; Tan Y; Wang D; Wang Y; Zhao C; Yi Y; Xiong M; Lv W; Wu M; Li X; Wu Y; Zhang Q
Front Cell Dev Biol; 2021; 9():647736. PubMed ID: 33777954
[TBL] [Abstract][Full Text] [Related]
14. Landscape of circular RNAs in different types of lung cancer and an emerging role in therapeutic resistance (Review).
Wang F; Yu C; Chen L; Xu S
Int J Oncol; 2023 Feb; 62(2):. PubMed ID: 36562354
[TBL] [Abstract][Full Text] [Related]
15. Current evidence on circRNAs as potential theranostic markers for detecting chemoresistance in breast cancer: a systematic review and meta‑analysis.
Zhu Z; Jiang H; Xie J; Jin X; Li B; Liu J
Sci Rep; 2022 Dec; 12(1):22016. PubMed ID: 36539545
[TBL] [Abstract][Full Text] [Related]
16. circRNAs and their relationship with breast cancer: a review.
Zhang F; Li L; Fan Z
World J Surg Oncol; 2022 Nov; 20(1):373. PubMed ID: 36443878
[TBL] [Abstract][Full Text] [Related]
17. The Role of Circular RNAs in the Drug Resistance of Cancers.
Liu XY; Zhang Q; Guo J; Zhang P; Liu H; Tian ZB; Zhang CP; Li XY
Front Oncol; 2021; 11():790589. PubMed ID: 35070998
[TBL] [Abstract][Full Text] [Related]
18. circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer.
Sang Y; Chen B; Song X; Li Y; Liang Y; Han D; Zhang N; Zhang H; Liu Y; Chen T; Li C; Wang L; Zhao W; Yang Q
Mol Ther; 2019 Sep; 27(9):1638-1652. PubMed ID: 31153828
[TBL] [Abstract][Full Text] [Related]
19. Circular RNA and its potential diagnostic and therapeutic values in breast cancer.
Gao D; Cui C; Jiao Y; Zhang H; Li M; Wang J; Sheng X
Mol Biol Rep; 2024 Feb; 51(1):258. PubMed ID: 38302635
[TBL] [Abstract][Full Text] [Related]
20. Unearthing Regulatory Axes of Breast Cancer circRNAs Networks to Find Novel Targets and Fathom Pivotal Mechanisms.
Afzali F; Salimi M
Interdiscip Sci; 2019 Dec; 11(4):711-722. PubMed ID: 31187432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
